Semaglutide modulates adipogenic differentiation and extracellular acidification in epicardial (EAT) and subcutaneous (SAT) adipose tissue stromal cells from patients with cardiovascular disease.
30 August 2024 (08:00 - 17:30)
Organised by: 

About the speaker

Health Research Institute, Santiago de Compostela (Spain)
8 More presentations in this session
Doctor S. Saeedi (Schlieren, CH)
Doctor M. Takahashi (Oita, JP)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
